Insights from 2023 ASH Annual Meeting
Playback speed
10 seconds
Final 48-Week Results of the APPLY-PNH Trial: Long-Term Efficacy & Safety in Anti-C5-Treated Patients With PNH & Persistent Anemia Undergoing Factor B Inhibition With Oral Iptacopan Monotherapy
By
Insights from 2023 ASH Annual Meeting
FEATURING
Carlos de Castro
By
Insights from 2023 ASH Annual Meeting
FEATURING
Carlos de Castro
304 views
April 3, 2024
Comments 0
Login to view comments.
Click here to Login
Benign Hematology